ORIC Pharmaceuticals Inc.
10.22
0.31 (3.13%)
At close: Jan 15, 2025, 9:57 AM

ORIC Pharmaceuticals Statistics

Share Statistics

ORIC Pharmaceuticals has 70.57M shares outstanding. The number of shares has increased by 4.74% in one year.

Shares Outstanding 70.57M
Shares Change (YoY) n/a
Shares Change (QoQ) 0.03%
Owned by Institutions (%) n/a
Shares Floating 45.95M
Failed to Deliver (FTD) Shares 4.20K
FTD / Avg. Volume 0.96%

Short Selling Information

The latest short interest is 11.21M, so 15.88% of the outstanding shares have been sold short.

Short Interest 11.21M
Short % of Shares Out 15.88%
Short % of Float 26.65%
Short Ratio (days to cover) 32.63

Valuation Ratios

The PE ratio is -4.7 and the forward PE ratio is -5.05.

PE Ratio -4.7
Forward PE -5.05
PS Ratio 0
Forward PS 44.5
PB Ratio 2.11
P/FCF Ratio -5.47
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for ORIC Pharmaceuticals Inc..

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 10.39, with a Debt / Equity ratio of 0.

Current Ratio 10.39
Quick Ratio 10.39
Debt / Equity 0
Total Debt / Capitalization 0
Cash Flow / Debt 0
Interest Coverage 0

Financial Efficiency

Return on equity (ROE) is -0.45% and return on capital (ROIC) is -47.28%.

Return on Equity (ROE) -0.45%
Return on Assets (ROA) -0.4%
Return on Capital (ROIC) -47.28%
Revenue Per Employee 0
Profits Per Employee -899.08K
Employee Count 112
Asset Turnover 0
Inventory Turnover 0

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by 18.71% in the last 52 weeks. The beta is 1.12, so ORIC Pharmaceuticals 's price volatility has been higher than the market average.

Beta 1.12
52-Week Price Change 18.71%
50-Day Moving Average 9.07
200-Day Moving Average 9.34
Relative Strength Index (RSI) 61.23
Average Volume (20 Days) 437.98K

Income Statement

Revenue n/a
Gross Profit -1.03M
Operating Income -110.78M
Net Income -100.70M
EBITDA -109.75M
EBIT n/a
Earnings Per Share (EPS) -1.96
Full Income Statement

Balance Sheet

The company has 23.38M in cash and 10.21M in debt, giving a net cash position of 13.17M.

Cash & Cash Equivalents 23.38M
Total Debt 10.21M
Net Cash 13.17M
Retained Earnings -434.93M
Total Assets 302.07M
Working Capital 258.18M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -85.69M and capital expenditures -849.00K, giving a free cash flow of -86.54M.

Operating Cash Flow -85.69M
Capital Expenditures -849.00K
Free Cash Flow -86.54M
FCF Per Share -1.68
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ORIC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -19.8%
FCF Yield -12.39%
Dividend Details

Analyst Forecast

The average price target for ORIC is $19, which is 91.9% higher than the current price. The consensus rating is "Buy".

Price Target $19
Price Target Difference 91.9%
Analyst Consensus Buy
Analyst Count 9
Stock Forecasts

Scores

Altman Z-Score 9.54
Piotroski F-Score 3